Eur Heart J: Incidence, risk factors and death of atrial fibrillation in breast cancer patients

In a multi-ethnic representative cohort of breast cancer patients in the United States , the incidence, prevalence, risk factors, and death outcomes of atrial fibrillation (AF) are not yet clear
.

Recently, the heart blood vessels magazine field authority Eur Heart published a research article on J, the purpose of this study was to evaluate breast cancer patients nationwide AF incidence, risk factors and related mortality

Breast cancer heart blood vessels

Researchers used surveillance, epidemiology, and final results and medical insurance-related databases to identify women over the age of 66 who were newly diagnosed with breast cancer between 2007 and 2014
.

These patients were matched 1:1 with health insurance participants who did not have cancer, and each pair was followed up for 1 year to determine the main outcome of AF

diagnosis

The researchers calculated the cumulative incidence using competitive risk survival statistics
.

After that, the researchers used the adjusted Cox proportional hazards model to determine the risk factors for AF in breast cancer patients

The study included 85,423 breast cancer patients, of which 9,425 (11.
0%) had been diagnosed with AF before breast cancer was diagnosed
.

Within 1 year after breast cancer diagnosis, 2993 (3.

It can be seen that the incidence of AF is significantly higher in women after the diagnosis of breast cancer
.

A higher breast cancer stage at diagnosis is significantly associated with a higher risk of AF

After women diagnosed with breast cancer, the incidence of AF is significantly higher

Original source:

Avirup Guha.

Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis in this message